According to the 2021 WHO brain tumor classification scheme (18), convexity and the majority of spinal meningiomas have similar molecular findings (loss of chromosome 22q and/or NF2 mutations), while skull base meningiomas demonstrate different mutations (AKT1, TRAF7, SMO, and PIK3CA). The gene discussed is SMO; the disease is meningioma.